• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
31 to 40 of 48 Results
Analyte Buprenorphine Complexity waived Effective Date To 07/29/2014
 < 
 1 
 2 
 3 
 4 
 5 
 > 
Results per Page

New Search
Export all 48 records to ExcelExport to Excel | Help | Download Files
Document Parent Analyte Analyte Specialty Effective Date
Cliawaived Inc. Instant Drug Test Cup  
K130665   Buprenorphine Toxicology / TDM 05/29/2013
Cliawaived Inc. Drug of Abuse Card  
K130665   Buprenorphine Toxicology / TDM 05/29/2013
US Diagnostics Inc. UScreen Drugs of Abuse Card  
K130665   Buprenorphine Toxicology / TDM 05/29/2013
US Diagnostics Inc. Uscreen Drug of Abuse Cup  
K130665   Buprenorphine Toxicology / TDM 05/29/2013
Alere iScreen DX Single Dip Card  
K022355   Buprenorphine Toxicology / TDM 05/29/2013
UCP Biosciences, Inc. UCP Home Drug Screening Test Cards  
K130463   Buprenorphine Toxicology / TDM 05/15/2013
UCP Biosciences, Inc. UCP Home Drug Screening Test Cups  
K130463   Buprenorphine Toxicology / TDM 05/15/2013
CLIAwaived Inc. Single Drug Dipstick Test  
K082508   Buprenorphine Toxicology / TDM 05/02/2013
CLIAwaived Inc. Rapid Dip Drug Test  
K082508   Buprenorphine Toxicology / TDM 05/02/2013
Guangzhou Wondfo Biotech Co., Ltd., Wondfo Multi-Drug Urine Test Panel  (Dip Card format)
K130665   Buprenorphine Toxicology / TDM 04/16/2013

-
-